LakeShore Biopharma Co., Ltd: eps_diluted
| Value | {"per": "shares", "amount": -0.57, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2023-04-01 – 2024-03-31 |
| Status | superseded |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ec58b418-7bac-405f-860f-909af3e17d8a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-069344Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/eps-diluted/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ec58b418-7bac-405f-860f-909af3e17d8a
History
- supersedes {"per": "shares", "amount": -4.05, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "CNY"} (evidence 0001213900-24-069344)